Drug – bio-affecting and body treating compositions – Natural resin – gum – or balsam as active ingredient
Reexamination Certificate
2005-04-26
2005-04-26
Leith, Patricia (Department: 1654)
Drug, bio-affecting and body treating compositions
Natural resin, gum, or balsam as active ingredient
Reexamination Certificate
active
06884421
ABSTRACT:
The present invention provides a synergistic pharmaceutical composition of butyric acid wheat fiber bran and guar gum and a method of treatment for diabetic nephropathy.
REFERENCES:
patent: 4968694 (1990-11-01), Madsen et al.
patent: 5789393 (1998-08-01), Dressman et al.
patent: 2002027941 (2002-12-01), None
Cameron-Smith, D et al., “Dietary Guar Gum Improves Insulin Sensitivity in Streptoszotocin-Induced Diabetic Rats,” The Journ of Nutrition: Feb. 1997, 127, 2, pp. 359-364.*
Nandini, C. D. etal., “Effect of Dietary Fibre on Intestinal and Renal Disaccharidases in Diabetic Rats,” Nutrition Research, Elsevier Science, 2000, vol. 20, No. 9, pp. 1301-1307.*
Kumar, C.M. et al., “Modulatory effect of butyric acid-a product of dietary fiber fermentation in experimentally induced diabetic rats,” Journal of Nutritional Biochemistry 13, (2002) pp. 522-527.*
Chethankumar, M. et al., “Butyric acid modulates activities on intestinal and renal disaccharidases in experimentally induced diabetic rats,” Nahrung/Food, 46 (2002) No. 5, pp. 345-348.*
Gallaher, D.D. et al., “Dietary guar gum halts further reanl enlargement in rats with established diabetes,” Journal of Nutrition, 1992 Dec.;122(12):2391-2397.
Nandini Chikunda Dattatreya
Salimath Paramahans Veerayya
Sambaiah Kari
Council of Scientific and Industrial Research
Leith Patricia
McCormick-Ewoldt Susan B.
Sughrue & Mion, PLLC
LandOfFree
Pharmaceutical composition for diabetic nephropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for diabetic nephropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for diabetic nephropathy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3430423